Corient Private Wealth’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
15,769
-344
-2% -$25.4K ﹤0.01% 1650
2026
Q1
$1.01M Sell
16,113
-2,113
-12% -$134K ﹤0.01% 1662
2025
Q4
$1.21M Buy
18,226
+551
+3% +$27K ﹤0.01% 1406
2025
Q3
$610K Buy
17,675
+619
+4% +$13.6K ﹤0.01% 1690
2025
Q2
$269K Buy
+17,056
New +$245K ﹤0.01% 2056
2024
Q1
Sell
-41,386
Closed -$1.27M 2281
2023
Q4
$1.27M Sell
41,386
-633
-2% -$16.8K ﹤0.01% 1197
2023
Q3
$1.13M Buy
42,019
+605
+1% +$18.5K ﹤0.01% 1146
2023
Q2
$1.48M Sell
41,414
-106
-0.3% -$3.65K ﹤0.01% 1008
2023
Q1
$1.05M Buy
+41,520
New +$1.31M ﹤0.01% 1064

Other funds holding ARWR

Corient Private Wealth's ARWR Position: Q2 2026 in Review

Corient Private Wealth reduced its Arrowhead Research (ARWR) stake by 2.1% in Q2 2026, selling an estimated $25.4K and leaving 15,769 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

Corient Private Wealth first reported a position in ARWR in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.48M in Q2 2023. 501 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

  • Corient Private Wealth held 15,769 shares of Arrowhead Research worth $1.29M as of Q2 2026.
  • Corient Private Wealth sold 344 Arrowhead Research shares in Q2 2026, an estimated $25.4K.
  • Arrowhead Research made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1650 holding.
  • Corient Private Wealth first reported a position in Arrowhead Research in Q1 2023 and has held it in 9 quarters since.
  • Corient Private Wealth's Arrowhead Research position peaked at $1.48M in Q2 2023.
  • 501 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.